{"id":"NCT01761266","sponsor":"Eisai Limited","briefTitle":"A Multicenter, Open-Label, Phase 3 Trial to Compare the Efficacy and Safety of Lenvatinib (E7080) Versus Sorafenib in First-line Treatment of Participants With Unresectable Hepatocellular Carcinoma","officialTitle":"A Multicenter, Randomized, Open-Label, Phase 3 Trial to Compare the Efficacy and Safety of Lenvatinib (E7080) Versus Sorafenib in First-Line Treatment of Subjects With Unresectable Hepatocellular Carcinoma","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-03-01","primaryCompletion":"2016-11-13","completion":"2021-03-10","firstPosted":"2013-01-04","resultsPosted":"2018-09-25","lastUpdate":"2022-04-05"},"enrollment":954,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Hepatocellular Carcinoma (HCC)"],"interventions":[{"type":"DRUG","name":"Lenvatinib","otherNames":["E7080, Lenvima"]},{"type":"DRUG","name":"Sorafenib","otherNames":[]}],"arms":[{"label":"Lenvatinib","type":"ACTIVE_COMPARATOR"},{"label":"Sorafenib","type":"ACTIVE_COMPARATOR"}],"summary":"E7080-G000-304 is a multicenter, randomized, open-label, noninferiority Phase 3 study to compare the efficacy and safety of lenvatinib versus sorafenib as a first-line systemic treatment in participants with unresectable Hepatocellular Carcinoma (HCC).","primaryOutcome":{"measure":"Overall Survival (OS)","timeFrame":"From date of randomization until date of death from any cause (approximately up to 3.8 years)","effectByArm":[{"arm":"Lenvatinib","deltaMin":13.6,"sd":12.1},{"arm":"Sorafenib","deltaMin":12.3,"sd":10.4}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":186,"countries":["United States","Australia","Belgium","Canada","China","France","Germany","Hong Kong","Israel","Italy","Japan","Malaysia","Philippines","Poland","Russia","Singapore","South Korea","Spain","Taiwan","Thailand","United Kingdom"]},"refs":{"pmids":["38261521","36341767","36051472","34087115","33948712","32265508","31720835","31249394","29433850"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":209,"n":476},"commonTop":["Diarrhoea","Palmar-plantar erythrodysaesthesia syndrome","Hypertension","Decreased appetite","Fatigue"]}}